Dr. Richard S. Schottenfeld is one of the nation’s foremost innovators in the field of substance use disorders.
WASHINGTON, D.C. (October 5, 2017) – Dr. Richard S. Schottenfeld, one of the nation’s foremost innovators in the field of substance use disorders, has been named the new chair of the Department of Psychiatry and Behavioral Sciences at Howard University. Dr. Schottenfeld previously directed major programs related to substance use disorders at Yale University
WASHIGNTON, D.C. (Sept. 11, 2017) -- Legendary surgeon Dr. LaSalle D. Leffall Jr. was recently honored with the Howard University College of Medicine Distinguished Alumni Award at the 2017 National Medical Association annual convention in Philadelphia.
WASHINGTON, D. C. (August 29, 2017) – Howard University and Howard University Hospital recently announced the appointment of James G. Taylor VI, M.D., director of the Center for Sickle Cell Disease, a key institute for the study of new sickle cell drugs.
Dean of the College of Medicine and Vice President of Clinical Affairs Dr. Hugh E. Mighty announced Dr. Taylor’s appointment as professor in the Department of Medicine, Division of Hematology/Oncology. Dr. Taylor will also be an attending physician at Howard University Hospital.
To the Howard University College of Medicine Community:
Howard University College of Medicine Receives Full Accreditation
The accrediting team noted the college’s strong commitments to diversity, providing academic assistance to students, and meeting the health care needs of underserved communities.
WASHINGTON, D.C. (August 16, 2017) –The Howard University College of Medicine has been granted continued full accreditation by the Liaison Committee on Medical Education, or LCME. The LCME is the national accrediting authority for medical education programs leading to M.D. degrees in the United States and Canada.
Howard University Cancer Center and Howard University Hospital announce the arrival of Vinita Singh, M.D., as its newest cancer physician. Dr. Singh brings more than 25 years of experience in oncology, internal medicine, and in hematology, or blood cancer.